Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
368 Results Found
AHA Comment Letter to DEA on Buprenorphine Telemedicine Prescribing Proposed Rule
AHA provides feedback on the Drug Enforcement Administration’s (DEA’s) proposed rule for expansion of induction of buprenorphine via telemedicine encounter.
AHA Support of FDA Blood Donation Eligibility Proposed Regulation
AHA comments on the FDA's draft guidance proposing that blood donor eligibility be determined based on individual risk assessment, regardless of gender or sexual orientation.
Maternal and Child Health Provisions Enacted in FY 2023 Omnibus Appropriations Package
The Consolidated Appropriations Act of 2023 (PL 117-328), signed into law in December 2022, contained a number of important maternal and child health provisions supported by the AHA.
AHA Comments on Proposed Revisions to the Regulations Governing the Confidentiality Of Substance Use Disorder Records
AHA comments proposed revisions to the regulations governing the confidentiality of substance use disorder (SUD) records, commonly known as 42 CFR Part 2 (“Part 2”).
AHA Comments on the CMS’ Request for Information on Essential Health Benefits (EHB)
AHA comments on the CMS’ Request for Information on Essential Health Benefits (EHB).
Better Health for Mothers and Babies
p, ul {
font-size: 16px;
color: #555
}
.field_featured_image {
position: absolute;
overflow: hidden;
clip: rect(0 0 0 0);
height: 1px; width: 1px;
margin: -1px
FDA Issues Draft Guidance Updating Blood Donation Policy
The Food and Drug Administration (FDA) Jan.
Medicare Physician Fee Schedule Final Rule for CY 2023
The Centers for Medicare & Medicaid Services (CMS) Nov. 1 issued its physician fee schedule (PFS) final rule for calendar year (CY) 2023.
AHA Letter to DEA Regarding Request for Release of Special Registration for Telemedicine Regulation
The AHA urges the DEA to release proposed rules for the Special Registration for Telemedicine as soon as possible. Doing so is necessary to ensure an appropriate feedback period and time for hospitals and health systems to comply with requirements.